Particle structure of an active ingredient from redworms to improve blood circulation
Patent Information
- Application Number
- DE202025103502
- Authority / Receiving Office
- DE · DE
- Patent Type
- Utility models
- Current Assignee / Owner
- Filing Date
- 2025-06-23
- Publication Date
- 2025-08-21
- Estimated Expiration
- 2035-06-30
Smart Images

Figure 00000000_0000_ABST
Abstract
Description
Field of the invention
[0001] The present invention relates to an edible particle structure and, in particular, to a particle structure of an active ingredient from redworms, which discloses an innovative construction. State of the art
[0002] The human body is a complex system whose all functions depend on proper blood circulation and a functioning metabolism. Therefore, many physical phenomena are interconnected, and every problem is closely linked. Poor circulation leads to poor metabolism and the inability to eliminate many waste products. Instead, they accumulate in the body, causing edema and pain. This pain leads to fatigue and sleep disturbances. Poor sleep leads to a weakened immune system and a greater risk of illness. All of these problems are directly related.
[0003] Common problems faced by modern people include fatigue, body aches, cold hands and feet, edema, skin problems, constipation or irregular bowel movements, sleep disorders, and increased susceptibility to infections. To effectively alleviate these symptoms, it is necessary to specifically treat the underlying cause, namely impaired blood circulation.
[0004] With the development of the global economy and rapid changes in people's living and working conditions, the incidence of thrombotic diseases is increasing year by year. Thromboembolic diseases include cerebral thrombosis, myocardial infarction, peripheral arterial thrombosis, and pulmonary embolism. These diseases now account for approximately 51% of all deaths worldwide.
[0005] Injuries or tears in blood vessels are temporarily closed by the formation of thrombi. After tissue regeneration is complete, vascular endothelial cells secrete plasminogen activators, which initiate the breakdown of the thrombus and restore blood circulation. Although the human body produces fibrinolytic enzymes to maintain the balance between the coagulation and fibrinolysis systems, this function declines with age. Studies show that approximately 50% of 60-year-olds already have thrombi in their vessels; in 70-year-olds, thrombi are detectable in almost 100% of cases. If the thrombus is too large and blocks blood circulation, it damages the body's internal structures and causes diseases such as heart attack, stroke, venous thrombosis, and hypertension, and can even be life-threatening.
[0006] Furthermore, humans are a link in the natural food chain. Natural foods represent an essential source of nutrients, and their growth is influenced by the quality of air, water, and soil. Over the last hundred years, the world's population has increased dramatically from 1 billion to over 7 billion people. The economic boom has led to a significant increase in meat consumption, requiring a significant increase in agricultural production to meet human food needs and the feed requirements of livestock.
[0007] Nutrition is the foundation of health. Food is the source of nutrients. A balanced diet is the most important principle for maintaining health. Such a diet must provide sufficient calories and essential nutrients daily to maintain bodily functions and prevent deficiencies and associated diseases.
[0008] However, nutrients generally suffer from the same deficiencies as many natural substances, such as low acid stability, limited storage life, and high susceptibility to degradation. Gastric and pancreatic juices, among others, are involved in the human digestive system. Due to the presence of gastric acid, many nutrients are destroyed during passage through the digestive tract, thereby losing their effectiveness, which severely limits their absorption rate in the body. Therefore, improvements and addressing the aforementioned deficiencies are necessary. Object of the invention
[0009] The main objective of the present invention is to provide a particle structure of an active ingredient derived from redworms for improving blood circulation. The technical problem to be solved is how to develop the structure of a novel, more optimal and practical edible particle.
[0010] The technical features of the redworm active ingredient particle structure for improving blood circulation according to the present invention, which can solve these problems, are described below. The redworm active ingredient particle structure comprises: an active core body, the main component of which is lumbrokinase derived from redworms; a protective surface layer covering the active core body to prevent the external environment from affecting the activity of the active core body, thus improving the storage stability of the redworm active ingredient particle structure and its absorption rate by the human body.
[0011] Compared with the conventional technology, the present invention, through its innovative and unique design, can provide a particle structure of a blood circulation-enhancing active ingredient derived from red worms, which can effectively dissolve thrombus, promote blood circulation, lower blood sugar and blood pressure, and improve dyslipidemia, thereby achieving the benefit and purpose of preventing diseases such as cerebral embolism, myocardial infarction, and pulmonary embolism. Furthermore, the protective surface layer acting as a coating can significantly extend the shelf life and maintain activity by avoiding damage caused by the external environment, thus achieving the industrial applicability of maintaining the activity and functionality of the active core body and increasing the absorption rate and product efficacy. Brief description of the drawings Fig. 1 shows a plan sectional view according to the present invention; Fig. Figure 2 shows a three-dimensional sectional view according to the present invention; Fig. 3 shows a plan sectional view of another embodiment according to the present invention. Detailed description of the implementation examples
[0012] It will be Fig. 1, which shows a preferred embodiment of the particle structure of an active ingredient from redworms for improving blood circulation. The following description only illustrates exemplary embodiments of the invention and is not to be understood as limiting the claims.
[0013] The particle structure of a redworm drug 1 comprises: an active core body 11, the main component of which is lumbrokinase derived from redworms; a protective surface layer 12 covering the active core body 11 to prevent the external environment from affecting the activity of the active core body, thus improving the storage stability of the particle structure of a redworm drug and its absorption rate by the human body.
[0014] Based on the above, the active ingredient in Nucleus Body 11 is red worm powder, which contains lumbrokinase with fibrinolytic activity. Lumbrokinase has the following functions: 1. Direct and rapid thrombus dissolution: Lumbrokinase with fibrinolytic activity detects and surrounds thrombi, acts only on thrombi and supports their rapid dissolution. 2. Indirect thrombus dissolution: Lumbrokinase promotes the production of fibrinolytic enzymes by vascular endothelial cells, thus contributing to thrombus dissolution. 3. Effective breakdown of blood lipids: Lumbrokinase supports lipid metabolism and reduces the accumulation of blood lipids, thereby preventing vascular constriction. 4. Blood vessel dilation and rapid improvement of microcirculation disorders: Lumbrokinase helps with blood circulation and vasodilation, especially for the treatment of peripheral microcirculation disorders such as diabetes (eyes, inner ear, extremities). 5. Effective stabilization of blood pressure: Lumbrokinase can be used as an adjunctive treatment for hypertension without affecting the dosage of conventional medications. 6. Regulation of blood sugar levels: Lumbrokinase can rapidly improve type 2 diabetes caused by impaired blood flow to the pancreas.
[0015] As mentioned above, the active core body 11 can be protected from influences and damages by the external environment by the protective surface layer 12 serving as a sheath, thereby maintaining its functionality and improving its absorption rate.
[0016] It will be Fig.2, which shows another embodiment of the present invention. The main difference from the preferred embodiment is that an enteric film 13 is further provided between the active core body 11 and the protective surface layer 12 to prevent the active core body 11 from being destroyed by gastric acid in the human digestive tract, thereby further improving the absorption rate of the active core body 11 in the human body. In the practice, the enteric film 13 is made of one of the following materials or a combination thereof: pectin, trehalose, polyunsaturated fatty acid, or amino acid.
[0017] The protective surface layer 12 consists of one of the following proteins or a combination thereof: pea protein, corn protein, yeast protein or potato protein.
[0018] Furthermore, the present invention can be manufactured in various dosage forms, e.g., as capsules, powder sachets, tablets, or packaged in cans, to meet different usage needs and occasions. It can be administered either directly orally or after dissolving in a liquid, for consumption, but the present invention is not subject to any limitations in this regard.
[0019] The active ingredient particles from redworms can be taken directly orally or dissolved in a liquid and drunk. Beneficial effects:
[0020] The present invention provides a particle structure of an active ingredient derived from red worms for improving blood circulation. The beneficial effects include effective thrombus dissolution, promoting blood circulation, lowering blood sugar and blood pressure, and improving dyslipidemia, thus achieving the prevention of diseases such as cerebral embolism, myocardial infarction, and pulmonary embolism.
[0021] In addition, the protective surface layer serving as a coating can significantly extend the shelf life and maintain the activity by avoiding damage caused by the external environment, so as to achieve the industrial applicability of maintaining the activity and functionality of the active core body and increasing the absorption rate and product efficacy.
[0022] The present invention provides a redworm active ingredient particle structure for improving blood circulation, comprising: an active core body whose main component is lumbrokinase derived from redworms; a protective surface layer coating the active core body to prevent the external environment from affecting the activity of the active core body, thus improving the storage stability of the redworm active ingredient particle structure and its absorption rate by the human body.
Claims
[1] Particle structure of an active ingredient from redworms for improving blood circulation, the particle structure of an active ingredient from redworms (1) comprising: an active nuclear body (11), the main component of which is lumbrokinase obtained from red worms; and a protective surface layer (12) surrounding the active core body (11) to prevent the external environment from influencing the activity of the active core body (11), and thus to improve the storage stability of the particle structure of an active ingredient from red worms (1) and its absorption rate by the human body. [2] A redworm active ingredient particle structure for improving blood circulation according to claim 1, wherein, when the redworm active ingredient particle structure (1) is in an edible or drinkable form, a gastric acid-resistant film (13) is further provided between the active core body (11) and the protective surface layer (12). [3] A particle structure of a blood circulation improving active ingredient from red worms according to claim 2, wherein the enteric film (13) is made of one of the following materials or a combination thereof: pectin, trehalose, polyunsaturated fatty acid or amino acid. [4] A particle structure of a redworm active ingredient for improving blood circulation according to claim 1, wherein the protective surface layer (12) consists of one of the following proteins or a combination thereof: pea protein, corn protein, yeast protein or potato protein.